Electroporation of pp60c− Antibodies Inhibits the Angiotensin II Activation of Phospholipase C-γ1 in Rat Aortic Smooth Muscle Cells

Our previous study has shown that angiotensin II induces the rapid tyrosine phosphorylation and activation of phospholipase C-γ1 in cultured rat aortic smooth muscle (RASM) cells (Marrero, M. B., Paxton, W. G., Duff, J. L., Berk, B. C., and Bernstein, K. E.(1994) J. Biol. Chem. 269, 10935-10939). This signaling pathway is initiated by ligand binding to the AT1 receptor, a cell surface G protein-coupled receptor. Antibodies to pp60c−src were introduced into RASM cells by electroporation. Angiotensin II-stimulated tyrosine phosphorylation of phospholipase C-γ1 was eliminated by the anti-pp60c−src antibodies but not by anti-mouse IgG or bovine serum albumin. Angiotensin II also induced the rapid tyrosine phosphorylation of pp120, a known pp60c−src kinase substrate, and this phosphorylation was also specifically inhibited by anti-pp60c−src antibodies. Electroporation of RASM cells with anti-pp60c−src antibodies had no effect on platelet-derived growth factor-stimulated tyrosine phosphorylation of PLC-γ1. Anti-pp60c−src also reduced the angiotensin II-stimulated inositol 1,4,5-trisphosphate production by 78%, while it had no effect on the platelet-derived growth factor-stimulated inositol 1,4,5-trisphosphate production. These data provide the first evidence for a direct involvement of pp60c−src kinase in angiotensin II-mediated PLC-γ1 phosphorylation and activation. Furthermore, it also describes a pathway in which a seven-transmembrane receptor can stimulate an intracellular tyrosine kinase. Our previous study has shown that angiotensin II induces the rapid tyrosine phosphorylation and activation of phospholipase C-γ1 in cultured rat aortic smooth muscle (RASM) cells (Marrero, M. B., Paxton, W. G., Duff, J. L., Berk, B. C., and Bernstein, K. E.(1994) J. Biol. Chem. 269, 10935-10939). This signaling pathway is initiated by ligand binding to the AT1 receptor, a cell surface G protein-coupled receptor. Antibodies to pp60c−src were introduced into RASM cells by electroporation. Angiotensin II-stimulated tyrosine phosphorylation of phospholipase C-γ1 was eliminated by the anti-pp60c−src antibodies but not by anti-mouse IgG or bovine serum albumin. Angiotensin II also induced the rapid tyrosine phosphorylation of pp120, a known pp60c−src kinase substrate, and this phosphorylation was also specifically inhibited by anti-pp60c−src antibodies. Electroporation of RASM cells with anti-pp60c−src antibodies had no effect on platelet-derived growth factor-stimulated tyrosine phosphorylation of PLC-γ1. Anti-pp60c−src also reduced the angiotensin II-stimulated inositol 1,4,5-trisphosphate production by 78%, while it had no effect on the platelet-derived growth factor-stimulated inositol 1,4,5-trisphosphate production. These data provide the first evidence for a direct involvement of pp60c−src kinase in angiotensin II-mediated PLC-γ1 phosphorylation and activation. Furthermore, it also describes a pathway in which a seven-transmembrane receptor can stimulate an intracellular tyrosine kinase.